P Hermida-Cabrera, F Aguilera, F Vivancos-Cuadras, L Ferrá-Domingo, D Torres-Lagares, J Gutiérrez-Pérez, T Pereira-Riveros, T-V Serrera-Figallo, M Baus-Domínguez
{"title":"在对 I 级和 II 级牙周病患者进行洗牙和根面平整治疗后,对一种由洗必泰和赛美诺配制的新型漱口水进行评估。","authors":"P Hermida-Cabrera, F Aguilera, F Vivancos-Cuadras, L Ferrá-Domingo, D Torres-Lagares, J Gutiérrez-Pérez, T Pereira-Riveros, T-V Serrera-Figallo, M Baus-Domínguez","doi":"10.4317/medoral.26818","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Periodontal disease is a multifactorial pathology whose treatment protocol is becoming increasingly\nstandardized, relying, among others, on adjuvant therapies. This study aims to determine the efficacy of a new\nchlorhexidine compound compared with the gold standard 0.12% chlorhexidine during periodontal maintenance\nof a patient with periodontitis grade I or II after scaling and root planing treatment.</p><p><strong>Material and methods: </strong>A parallel, randomized, double-blind clinical trial with two arms: (A) treatment with\n0.12% chlorhexidine mouthwash; (B) treatment with new chlorhexidine mouthwash containing O-Cymen-5-Ol.\nThe patient was examined: (D0) initial examination, (D7) clinical examination one week after treatment, (D14)\nclinical examination two weeks after treatment and (D28) clinical examination three weeks after treatment. They\nare collecting the following data: Plaque index (PI), gingival index (GI), bleeding index (BoP), pocket depth (PS),\nand attachment loss (CAL).</p><p><strong>Results: </strong>After a follow-up of 43 patients, no statistically significant differences were found between the groups at\nany of the times or for any of the parameters evaluated, meeting the predefined criteria of non-inferiority.</p><p><strong>Conclusions: </strong>The new chlorhexidine mouthwash proved to be non-inferior to 0.12% chlorhexidine in terms of efficacy\nduring short-term periodontal maintenance after scaling and root planing.</p>","PeriodicalId":49016,"journal":{"name":"Medicina Oral Patologia Oral Y Cirugia Bucal","volume":" ","pages":"e843-e849"},"PeriodicalIF":1.8000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11584970/pdf/","citationCount":"0","resultStr":"{\"title\":\"Evaluation of a new mouthwash formulated with Chlorhexidine and Cymenol after a scaling and root planing treatment in grade I and II periodontal patients.\",\"authors\":\"P Hermida-Cabrera, F Aguilera, F Vivancos-Cuadras, L Ferrá-Domingo, D Torres-Lagares, J Gutiérrez-Pérez, T Pereira-Riveros, T-V Serrera-Figallo, M Baus-Domínguez\",\"doi\":\"10.4317/medoral.26818\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Periodontal disease is a multifactorial pathology whose treatment protocol is becoming increasingly\\nstandardized, relying, among others, on adjuvant therapies. This study aims to determine the efficacy of a new\\nchlorhexidine compound compared with the gold standard 0.12% chlorhexidine during periodontal maintenance\\nof a patient with periodontitis grade I or II after scaling and root planing treatment.</p><p><strong>Material and methods: </strong>A parallel, randomized, double-blind clinical trial with two arms: (A) treatment with\\n0.12% chlorhexidine mouthwash; (B) treatment with new chlorhexidine mouthwash containing O-Cymen-5-Ol.\\nThe patient was examined: (D0) initial examination, (D7) clinical examination one week after treatment, (D14)\\nclinical examination two weeks after treatment and (D28) clinical examination three weeks after treatment. They\\nare collecting the following data: Plaque index (PI), gingival index (GI), bleeding index (BoP), pocket depth (PS),\\nand attachment loss (CAL).</p><p><strong>Results: </strong>After a follow-up of 43 patients, no statistically significant differences were found between the groups at\\nany of the times or for any of the parameters evaluated, meeting the predefined criteria of non-inferiority.</p><p><strong>Conclusions: </strong>The new chlorhexidine mouthwash proved to be non-inferior to 0.12% chlorhexidine in terms of efficacy\\nduring short-term periodontal maintenance after scaling and root planing.</p>\",\"PeriodicalId\":49016,\"journal\":{\"name\":\"Medicina Oral Patologia Oral Y Cirugia Bucal\",\"volume\":\" \",\"pages\":\"e843-e849\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2024-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11584970/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medicina Oral Patologia Oral Y Cirugia Bucal\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.4317/medoral.26818\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"DENTISTRY, ORAL SURGERY & MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicina Oral Patologia Oral Y Cirugia Bucal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4317/medoral.26818","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"DENTISTRY, ORAL SURGERY & MEDICINE","Score":null,"Total":0}
Evaluation of a new mouthwash formulated with Chlorhexidine and Cymenol after a scaling and root planing treatment in grade I and II periodontal patients.
Background: Periodontal disease is a multifactorial pathology whose treatment protocol is becoming increasingly
standardized, relying, among others, on adjuvant therapies. This study aims to determine the efficacy of a new
chlorhexidine compound compared with the gold standard 0.12% chlorhexidine during periodontal maintenance
of a patient with periodontitis grade I or II after scaling and root planing treatment.
Material and methods: A parallel, randomized, double-blind clinical trial with two arms: (A) treatment with
0.12% chlorhexidine mouthwash; (B) treatment with new chlorhexidine mouthwash containing O-Cymen-5-Ol.
The patient was examined: (D0) initial examination, (D7) clinical examination one week after treatment, (D14)
clinical examination two weeks after treatment and (D28) clinical examination three weeks after treatment. They
are collecting the following data: Plaque index (PI), gingival index (GI), bleeding index (BoP), pocket depth (PS),
and attachment loss (CAL).
Results: After a follow-up of 43 patients, no statistically significant differences were found between the groups at
any of the times or for any of the parameters evaluated, meeting the predefined criteria of non-inferiority.
Conclusions: The new chlorhexidine mouthwash proved to be non-inferior to 0.12% chlorhexidine in terms of efficacy
during short-term periodontal maintenance after scaling and root planing.
期刊介绍:
1. Oral Medicine and Pathology:
Clinicopathological as well as medical or surgical management aspects of
diseases affecting oral mucosa, salivary glands, maxillary bones, as well as
orofacial neurological disorders, and systemic conditions with an impact on
the oral cavity.
2. Oral Surgery:
Surgical management aspects of diseases affecting oral mucosa, salivary glands,
maxillary bones, teeth, implants, oral surgical procedures. Surgical management
of diseases affecting head and neck areas.
3. Medically compromised patients in Dentistry:
Articles discussing medical problems in Odontology will also be included, with
a special focus on the clinico-odontological management of medically compromised patients, and considerations regarding high-risk or disabled patients.
4. Implantology
5. Periodontology